Rock Creek Pharmaceuticals, Inc.Company Review & Valuation

RCPIQ
OTC Markets
Latest Price
0.00USD
Market Capitalization
221.58kUSD

About Rock Creek Pharmaceuticals, Inc.

Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits aShow morenti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.Show less

Industry
Biotechnology
HQ Location
Sarasota, Florida

Stock Price

Price data not available for Rock Creek Pharmaceuticals, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Apricus Biosciences
Regeneron Pharmaceuticals
Amgen
Alexion Pharmaceuticals

back to top